• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical, Radiographic and Histopathological Analysis of Craniopharyngiomas and Ameloblastomas: A Systematic Review.颅咽管瘤和造釉细胞瘤的临床、影像学和组织病理学分析:系统评价。
Head Neck Pathol. 2022 Dec;16(4):1195-1222. doi: 10.1007/s12105-022-01473-2. Epub 2022 Aug 3.
2
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
3
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
7
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
8
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.

引用本文的文献

1
Comparative Immunohistochemical Analysis of Craniopharyngioma and Ameloblastoma: Insights into Odontogenic Differentiation.颅咽管瘤和成釉细胞瘤的比较免疫组织化学分析:对牙源性分化的见解
Diagnostics (Basel). 2024 Oct 17;14(20):2315. doi: 10.3390/diagnostics14202315.
2
Association of MDM2 Overexpression in Ameloblastomas with Amplification and BRAF Expression.成釉细胞瘤中 MDM2 过表达与扩增和 BRAF 表达的关联。
Int J Mol Sci. 2024 Feb 13;25(4):2238. doi: 10.3390/ijms25042238.
3
Implant-supported prosthetic rehabilitation after Ameloblastomas treatment: a systematic review.牙瘤治疗后种植体支持的修复:系统评价。
BMC Oral Health. 2023 Dec 18;23(1):1013. doi: 10.1186/s12903-023-03765-7.
4
Clinicopathologic Profile, Management and Outcome of Sinonasal Ameloblastoma-A Systematic Review.鼻窦成釉细胞瘤的临床病理特征、治疗及预后——一项系统评价
J Clin Med. 2023 Jan 3;12(1):381. doi: 10.3390/jcm12010381.

本文引用的文献

1
Craniopharyngiomas, including Recurrent Cases, Lack TERT Promoter Hotspot Mutations.颅咽管瘤,包括复发病例,缺乏 TERT 启动子热点突变。
Neurol Med Chir (Tokyo). 2021 Jun 15;61(6):385-391. doi: 10.2176/nmc.rc.2020-0339. Epub 2021 May 8.
2
Predictors of Postoperative Visual Outcome After Surgical Intervention for Craniopharyngiomas.颅咽管瘤手术干预后术后视觉结局的预测因素。
World Neurosurg. 2021 Apr;148:e589-e599. doi: 10.1016/j.wneu.2021.01.044. Epub 2021 Jan 20.
3
Controversies in ameloblastoma management: evaluation of decision making, based on a retrospective analysis.成釉细胞瘤治疗的争议:基于回顾性分析的决策评估。
Med Oral Patol Oral Cir Bucal. 2021 Mar 1;26(2):e181-e186. doi: 10.4317/medoral.24104.
4
Retrospective analysis of Desmoplastic Ameloblastoma: Clinical review.促结缔组织增生型成釉细胞瘤的回顾性分析:临床综述。
Med Oral Patol Oral Cir Bucal. 2021 Mar 1;26(2):e246-e255. doi: 10.4317/medoral.24152.
5
Maxillary Ameloblastoma: A Review With Clinical, Histological and Prognostic Data of a Rare Tumor.上颌骨造釉细胞瘤:一种罕见肿瘤的临床、组织学和预后数据的综述。
In Vivo. 2020 Sep-Oct;34(5):2249-2258. doi: 10.21873/invivo.12035.
6
Craniopharyngioma.颅咽管瘤。
Nat Rev Dis Primers. 2019 Nov 7;5(1):75. doi: 10.1038/s41572-019-0125-9.
7
Clinical Situation, Therapy, and Follow-Up of Adult Craniopharyngioma.成人颅咽管瘤的临床情况、治疗和随访。
J Clin Endocrinol Metab. 2020 Jan 1;105(1). doi: 10.1210/clinem/dgz043.
8
Pediatric craniopharyngioma.小儿颅咽管瘤
Childs Nerv Syst. 2019 Nov;35(11):2133-2145. doi: 10.1007/s00381-019-04300-2. Epub 2019 Aug 5.
9
Management of Craniopharyngioma.颅咽管瘤的管理
J Craniofac Surg. 2019 Mar/Apr;30(2):e178-e183. doi: 10.1097/SCS.0000000000005136.
10
Craniopharyngiomas and odontogenic tumors mimic normal odontogenesis and share genetic mutations, histopathologic features, and molecular pathways activation.颅咽管瘤和牙源性肿瘤模拟正常牙发生,具有遗传突变、组织病理学特征和分子途径激活的特点。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Mar;127(3):231-236. doi: 10.1016/j.oooo.2018.11.004. Epub 2018 Nov 16.

颅咽管瘤和造釉细胞瘤的临床、影像学和组织病理学分析:系统评价。

Clinical, Radiographic and Histopathological Analysis of Craniopharyngiomas and Ameloblastomas: A Systematic Review.

机构信息

Federal University of Rio Grande do Norte (UFRN), Natal, RN, Brazil.

Postgraduate Program in Dental Sciences, Federal University of Rio Grande do Norte (UFRN), Natal, RN, Brazil.

出版信息

Head Neck Pathol. 2022 Dec;16(4):1195-1222. doi: 10.1007/s12105-022-01473-2. Epub 2022 Aug 3.

DOI:10.1007/s12105-022-01473-2
PMID:35920974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9729483/
Abstract

BACKGROUND

Craniopharyngiomas and ameloblastomas are tumors of epithelial origin, mostly characterized by a benign course, slow growth and for being locally invasive. Some studies highlight the similarity of these neoplasms, especially regarding histopathological aspects. In this context, the aim of the present study was to carry out a systematic literature review correlating the clinical, radiographic, and histopathological aspects of these two tumors.

METHODS

Searches were conducted at the Pubmed, Periódicos Capes, Scopus, Science Direct, Web of Science and Scielo databases, according to the following inclusion criteria: publications in English or Spanish, from the 2000s and 2021, comprising case report studies, case series and literature reviews.

RESULTS

Considering clinical and radiographic aspects, it is evident that craniopharyngiomas and ameloblastomas exhibit few similarities. Histopathologically, however, adamantinomatous craniopharyngiomas are the type of tumor that most resembles ameloblastomas, both concerning the formation of palisade epithelial cords and epithelial formations. Regarding to recurrences in cases of craniopharyngioma, it appears that a more radical surgical resection is more related to a lower recurrence rate for both craniopharyngiomas and ameloblastomas. As for the outcome, it was observed that craniopharyngiomas have a greater relationship with possible systemic disorders.

CONCLUSIONS

This histopathological similarity is related to their origin, since both craniopharyngiomas and ameloblastomas share a relationship with the oral cavity, either partially, as in the case of craniopharyngiomas, or totally, as in ameloblastomas, not comprising the same lesion in different locations. It is important to note that the differential morphogenetic evidence observed herein between these lesions opens up a new field of study aiming at better treatment alternatives in the future.

摘要

背景

颅咽管瘤和造釉细胞瘤是上皮来源的肿瘤,主要表现为良性病程、生长缓慢且具有局部侵袭性。一些研究强调了这些肿瘤的相似性,尤其是在组织病理学方面。在这种情况下,本研究的目的是对这两种肿瘤的临床、放射学和组织病理学方面进行系统的文献回顾。

方法

根据以下纳入标准,在 Pubmed、Periódicos Capes、Scopus、Science Direct、Web of Science 和 Scielo 数据库中进行了检索:发表在英语或西班牙语的文献,来自 21 世纪 00 年代和 2021 年,包括病例报告研究、病例系列和文献综述。

结果

考虑到临床和放射学方面,颅咽管瘤和造釉细胞瘤之间几乎没有相似之处。然而,在组织病理学方面,造釉细胞瘤中出现的牙釉质细胞瘤类型与造釉细胞瘤最为相似,这两种肿瘤都与栅栏状上皮索和上皮形成有关。关于颅咽管瘤的复发,似乎更彻底的手术切除与颅咽管瘤和造釉细胞瘤的较低复发率有关。至于结果,观察到颅咽管瘤与可能的全身疾病有更大的关系。

结论

这种组织病理学上的相似性与其起源有关,因为颅咽管瘤和造釉细胞瘤都与口腔有一定的关系,要么像颅咽管瘤那样部分相关,要么像造釉细胞瘤那样完全相关,不在不同部位形成相同的病变。值得注意的是,在此观察到的这些病变之间的形态发生差异证据开辟了一个新的研究领域,旨在为未来提供更好的治疗选择。